An intrinsically disordered region of methyl-CpG binding domain protein 2 (MBD2) recruits the histone deacetylase core of the NuRD complex

Nucleic Acids Research

Volumn 43, Issue 6, 2015, Pages 3100-3113

  Desai, Megha A ^a   Webb, Heather D ^a,d   Sinanan, Leander M ^b   Scarsdale, J Neel ^a   Walavalkar, Ninad M ^b,e   Ginder, Gordon D ^c   Williams, David C ^b  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^d GENESYS REGIONAL MEDICAL CENTER   (United States)

^e NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHD4 NUCLEOSOME REMODELING PROTEIN; HISTONE DEACETYLASE; HISTONE DEACETYLASE 2; METHYL CPG BINDING PROTEIN 2; MTA2 PROTEIN; NUCLEOSOME REMODELING AND DEACETYLASE COMPLEX; PROTEIN P66; RETINOBLASTOMA BINDING PROTEIN 4; UNCLASSIFIED DRUG; DNA BINDING PROTEIN; INTRINSICALLY DISORDERED PROTEIN; MBD2 PROTEIN, HUMAN; MBD2 PROTEIN, MOUSE; RECOMBINANT PROTEIN;

ARTICLE; BINDING AFFINITY; BREAST CANCER CELL LINE; CONTROLLED STUDY; DNA METHYLATION; GENE REPRESSION; HUMAN; HUMAN CELL; INTRINSICALLY DISORDERED REGION; PRIORITY JOURNAL; PROTEIN DNA BINDING; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; PRSS8 GENE; TUMOR SUPPRESSOR GENE; AMINO ACID SEQUENCE; ANIMAL; CELL LINE; CHEMICAL STRUCTURE; CHEMISTRY; GENE SILENCING; GENETIC EPIGENESIS; GENETICS; HEK293 CELL LINE; KINETICS; METABOLISM; MOLECULAR GENETICS; MOUSE; SEQUENCE HOMOLOGY; SITE DIRECTED MUTAGENESIS;

AMINO ACID SEQUENCE; ANIMALS; CELL LINE; DNA METHYLATION; DNA-BINDING PROTEINS; EPIGENESIS, GENETIC; GENE KNOCKDOWN TECHNIQUES; HEK293 CELLS; HUMANS; INTRINSICALLY DISORDERED PROTEINS; KINETICS; MI-2 NUCLEOSOME REMODELING AND DEACETYLASE COMPLEX; MICE; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; MUTAGENESIS, SITE-DIRECTED; PROTEIN INTERACTION DOMAINS AND MOTIFS; RECOMBINANT PROTEINS; SEQUENCE HOMOLOGY, AMINO ACID;

EID: 84942244451     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkv168     Document Type: Article

References (71)

1. Kim,J.K., Samaranayake,M. and Pradhan,S. (2009) Epigenetic mechanisms in mammals. Cell Mol. Life Sci., 66, 596-612.
2. Illingworth,R.S. and Bird,A.P. (2009) CpG islands-'a rough guide'. FEBS Lett., 583, 1713-1720.
3. Straussman,R., Nejman,D., Roberts,D., Steinfeld,I., Blum,B., Benvenisty,N., Simon,I., Yakhini,Z. and Cedar,H. (2009) Developmental programming of CpG island methylation profiles in the human genome. Nat. Struct. Mol. Biol., 16, 564-571.
4. Rupon,J.W., Wang,S.Z., Gaensler,K., Lloyd,J. and Ginder,G.D. (2006) Methyl binding domain protein 2 mediates gamma-globin gene silencing in adult human betaYAC transgenic mice. Proc. Natl. Acad. Sci. U.S.A., 103, 6617-6622.
5. Kransdorf,E.P., Wang,S.Z., Zhu,S.Z., Langston,T.B., Rupon,J.W. and Ginder,G.D. (2006) MBD2 is a critical component of a methyl cytosine-binding protein complex isolated from primary erythroid cells. Blood, 108, 2836-2845.
6. Berger,J., Sansom,O., Clarke,A. and Bird,A. (2007) MBD2 is required for correct spatial gene expression in the gut. Mol. Cell. Biol., 27, 4049-4057.
7. Jones,P.A. and Baylin,S.B. (2007) The epigenomics of cancer. Cell, 128, 683-692.
8. Meehan,R.R., Lewis,J.D., McKay,S., Kleiner,E.L. and Bird,A.P. (1989) Identification of a mammalian protein that binds specifically to DNA containing methylated CpGs. Cell, 58, 499-507.
9. Hendrich,B. and Bird,A. (1998) Identification and characterization of a family of mammalian methyl-CpG binding proteins. Mol. Cell. Biol., 18, 6538-6547.
10. Cramer,J.M., Scarsdale,J.N., Walavalkar,N.M., Buchwald,W.A., Ginder,G.D. and Williams,D.C. Jr (2014) Probing the dynamic distribution of bound states for methylcytosine-binding domains on DNA. J. Biol. Chem., 289, 1294-1302.
11. Hashimoto,H., Liu,Y., Upadhyay,A.K., Chang,Y., Howerton,S.B., Vertino,P.M., Zhang,X. and Cheng,X. (2012) Recognition and potential mechanisms for replication and erasure of cytosine hydroxymethylation. Nucleic Acids Res., 40, 4841-4849.
12. Saito,M. and Ishikawa,F. (2002) The mCpG-binding domain of human MBD3 does not bind to mCpG but interacts with NuRD/Mi2 components HDAC1 and MTA2. J. Biol. Chem., 277, 35434-35439.
13. Fraga,M.F., Ballestar,E., Montoya,G., Taysavang,P., Wade,P.A. and Esteller,M. (2003) The affinity of different MBD proteins for a specific methylated locus depends on their intrinsic binding properties. Nucleic Acids Res., 31, 1765-1774.
14. Feng,Q. and Zhang,Y. (2001) The MeCP1 complex represses transcription through preferential binding, remodeling, and deacetylating methylated nucleosomes. Genes Dev., 15, 827-832.
15. Kloet,S.L., Baymaz,H.I., Makowski,M., Groenewold,V., Jansen,P.W., Berendsen,M., Niazi,H., Kops,G.J. and Vermeulen,M. (2014) Towards elucidating the stability, dynamics and architecture of the nucleosome remodeling and deacetylase complex by using quantitative interaction proteomics. FEBS J., doi:10.1111/febs.12972.
16. Smits,A.H., Jansen,P.W., Poser,I., Hyman,A.A. and Vermeulen,M. (2013) Stoichiometry of chromatin-associated protein complexes revealed by label-free quantitative mass spectrometry-based proteomics. Nucleic Acids Res., 41, e28.
17. Singal,R., Wang,S.Z., Sargent,T., Zhu,S.Z. and Ginder,G.D. (2002) Methylation of promoter proximal-transcribed sequences of an embryonic globin gene inhibits transcription in primary erythroid cells and promotes formation of a cell type-specific methyl cytosine binding complex. J. Biol. Chem., 277, 1897-1905.
18. Gnanapragasam,M.N., Scarsdale,J.N., Amaya,M.L., Webb,H.D., Desai,M.A., Walavalkar,N.M., Wang,S.Z., Zu Zhu,S., Ginder,G.D. and Williams,D.C. Jr (2011) p66{alpha}-MBD2 coiled-coil interaction and recruitment of mi-2 are critical for globin gene silencing by the MBD2-NuRD complex. Proc. Natl. Acad. Sci. U.S.A., 108, 7487-7492.
19. Rupon,J.W., Wang,S.Z., Gnanapragasam,M., Labropoulos,S. and Ginder,G.D. (2011) MBD2 contributes to developmental silencing of the human epsilon-globin gene. Blood Cells Mol. Dis., 46, 212-219.
20. Mian,O.Y., Wang,S.Z., Zhu,S.Z., Gnanapragasam,M.N., Graham,L., Bear,H.D. and Ginder,G.D. (2011) Methyl-binding domain protein 2-dependent proliferation and survival of breast cancer cells. Mol. Cancer Res., 9, 1152-1162.
21. Magdinier,F. and Wolffe,A.P. (2001) Selective association of the methyl-CpG binding protein MBD2 with the silent p14/p16 locus in human neoplasia. Proc. Natl. Acad. Sci. U.S.A., 98, 4990-4995.
22. Sansom,O.J., Berger,J., Bishop,S.M., Hendrich,B., Bird,A. and Clarke,A.R. (2003) Deficiency of Mbd2 suppresses intestinal tumorigenesis. Nat. Genet., 34, 145-147.
23. Stefanska,B., Suderman,M., Machnes,Z., Bhattacharyya,B., Hallett,M. and Szyf,M. (2013) Transcription onset of genes critical in liver carcinogenesis is epigenetically regulated by methylated DNA-binding protein MBD2. Carcinogenesis, 34, 2738-2749.
24. Yu,S., Khor,T.O., Cheung,K.L., Li,W., Wu,T.Y., Huang,Y., Foster,B.A., Kan,Y.W. and Kong,A.N. (2010) Nrf2 expression is regulated by epigenetic mechanisms in prostate cancer of TRAMP mice. PLoS One, 5, e8579.
25. Lopez-Serra,L., Ballestar,E., Ropero,S., Setien,F., Billard,L.M., Fraga,M.F., Lopez-Nieva,P., Alaminos,M., Guerrero,D., Dante,R. et al. (2008) Unmasking of epigenetically silenced candidate tumor suppressor genes by removal of methyl-CpG-binding domain proteins. Oncogene, 27, 3556-3566.
26. Esteller,M. (2008) Epigenetics in cancer. N.Engl.J.Med., 358, 1148-1159.
27. Brackertz,M., Gong,Z., Leers,J. and Renkawitz,R. (2006) p66alpha and p66beta of the mi-2/NuRD complex mediate MBD2 and histone interaction. Nucleic Acids Res., 34, 397-406.
28. Tompa,P. (2012) Intrinsically disordered proteins: A 10-year recap. Trends Biochem. Sci., 37, 509-516.
29. Hameed,U.F., Lim,J., Zhang,Q., Wasik,M.A., Yang,D. and Swaminathan,K. (2014) Transcriptional repressor domain of MBD1 is intrinsically disordered and interacts with its binding partners in a selective manner. Sci. Rep., 4, e4896.
30. Adams,V.H., McBryant,S.J., Wade,P.A., Woodcock,C.L. and Hansen,J.C. (2007) Intrinsic disorder and autonomous domain function in the multifunctional nuclear protein, MeCP2. J. Biol. Chem., 282, 15057-15064.
31. Cai,M., Williams,D.C. Jr, Wang,G., Lee,B.R., Peterkofsky,A. and Clore,G.M. (2003) Solution structure of the phosphoryl transfer complex between the signal-transducing protein IIAGlucose and the cytoplasmic domain of the glucose transporter IICBGlucose of the escherichia coli glucose phosphotransferase system. J. Biol. Chem., 278, 25191-25206.
32. Walavalkar,N.M., Cramer,J.M., Buchwald,W.A., Scarsdale,J.N. and Williams,D.C. Jr (2014) Solution structure and intramolecular exchange of methyl-cytosine binding domain protein 4 (MBD4) on DNA suggests a mechanism to scan for mCpG/TpG mismatches. Nucleic Acids Res., 42, 11218-11232.
33. Scarsdale,J.N., Webb,H.D., Ginder,G.D. and Williams,D.C. Jr (2011) Solution structure and dynamic analysis of chicken MBD2 methyl binding domain bound to a target-methylated DNA sequence. Nucleic Acids Res., 39, 6741-6752.
34. Lebowitz,J., Lewis,M.S. and Schuck,P. (2002) Modern analytical ultracentrifugation in protein science: A tutorial review. Protein Sci., 11, 2067-2079.
35. Schuck,P. (2000) Size-distribution analysis of macromolecules by sedimentation velocity ultracentrifugation and lamm equation modeling. Biophys. J., 78, 1606-1619.
36. Walavalkar,N.M., Gordon,N. and Williams,D.C. Jr (2013) Unique features of the anti-parallel, heterodimeric coiled-coil interaction between methyl-cytosine binding domain 2 (MBD2) homologues and GATA zinc finger domain containing 2A (GATAD2A/p66alpha). J. Biol. Chem., 288, 3419-3427.
37. Kumita,J.R., Smart,O.S. and Woolley,G.A. (2000) Photo-control of helix content in a short peptide. Proc. Natl. Acad. Sci. U.S.A., 97, 3803-3808.
38. Delaglio,F., Grzesiek,S., Vuister,G.W., Zhu,G., Pfeifer,J. and Bax,A. (1995) NMRPipe: a multidimensional spectral processing system based on UNIX pipes. J. Biomol. NMR, 6, 277-293.
39. Vranken,W.F., Boucher,W., Stevens,T.J., Fogh,R.H., Pajon,A., Llinas,M., Ulrich,E.L., Markley,J.L., Ionides,J. and Laue,E.D. (2005) The CCPN data model for NMR spectroscopy: development of a software pipeline. Proteins, 59, 687-696.
40. Markley,J.L., Bax,A., Arata,Y., Hilbers,C.W., Kaptein,R., Sykes,B.D., Wright,P.E. and Wuthrich,K. (1998) Recommendations for the presentation of NMR structures of proteins and nucleic acids. IUPAC-IUBMB-IUPAB inter-union task group on the standardization of data bases of protein and nucleic acid structures determined by NMR spectroscopy. J. Biomol. NMR, 12, 1-23.
41. Kjaergaard,M. and Poulsen,F.M. (2011) Sequence correction of random coil chemical shifts: correlation between neighbor correction factors and changes in the ramachandran distribution. J. Biomol. NMR, 50, 157-165.
42. Kingston,R.E., Chen,C.A. and Okayama,H. (2003) Calcium phosphate transfection. Curr. Protoc. Cell. Biol., 19, 20.3.1-20.3.8.
43. Bjellqvist,B., Hughes,G.J., Pasquali,C., Paquet,N., Ravier,F., Sanchez,J.C., Frutiger,S. and Hochstrasser,D. (1993) The focusing positions of polypeptides in immobilized pH gradients can be predicted from their amino acid sequences. Electrophoresis, 14, 1023-1031.
44. Li,X., Romero,P., Rani,M., Dunker,A.K. and Obradovic,Z. (1999) Predicting protein disorder for N-, C-, and internal regions. Genome Inform. Ser. Workshop Genome Inform., 10, 30-40.
45. Romero,Obradovic, and Dunker,K. (1997) Sequence data analysis for long disordered regions prediction in the calcineurin family. Genome Inform. Ser. Workshop Genome Inform., 8, 110-124.
46. Fuxreiter,M. (2012) Fuzziness: linking regulation to protein dynamics. Mol. Biosyst, 8, 168-177.
47. Fuxreiter,M. and Tompa,P. (2012) Fuzzy complexes: a more stochastic view of protein function. Adv. Exp. Med. Biol., 725, 1-14.
48. Uversky,V.N. (2011) Intrinsically disordered proteins from A to Z. Int. J. Biochem. Cell Biol., 43, 1090-1103.
49. Vacic,V., Oldfield,C.J., Mohan,A., Radivojac,P., Cortese,M.S., Uversky,V.N. and Dunker,A.K. (2007) Characterization of molecular recognition features, MoRFs, and their binding partners. J. Proteome Res., 6, 2351-2366.
50. Mohan,A., Oldfield,C.J., Radivojac,P., Vacic,V., Cortese,M.S., Dunker,A.K. and Uversky,V.N. (2006) Analysis of molecular recognition features (MoRFs). J. Mol. Biol., 362, 1043-1059.
51. Jiang,C.L., Jin,S.G., Lee,D.H., Lan,Z.J., Xu,X., O'Connor,T.R., Szabó,P.E., Mann,J.R., Cooney,A.J. and Pfeifer,G.P. (2002) MBD3L1 and MBD3L2, two new proteins homologous to the methyl-CpG-binding proteins MBD2 and MBD3: characterization of MBD3L1 as a testis-specific transcriptional repressor. Genomics, 80, 621-629.
52. Jiang,C., Jin,S. and Pfeifer,G.P. (2004) MBD3L1 is a transcriptional repressor that interacts with methyl-CpG-binding protein 2 (MBD2) and components of the NuRD complex. J. Biol. Chem., 279, 52456-52464.
53. Jin,S., Jiang,C., Rauch,T., Li,H. and Pfeifer,G.P. (2005) MBD3L2 interacts with MBD3 and components of the NuRD complex and can oppose MBD2-MeCP1-mediated methylation silencing. J. Biol. Chem., 280, 12700-12709.
54. Ghosh,R.P., Nikitina,T., Horowitz-Scherer,R.A., Gierasch,L.M., Uversky,V.N., Hite,K., Hansen,J.C. and Woodcock,C.L. (2010) Unique properties and interactions of the domains of the methylated DNA binding protein 2 (MeCP2). Biochemistry, 49, 4395-4410.
55. Pontius,B.W. (1993) Close encounters: why unstructured, polymeric domains can increase rates of specific macromolecular association. Trends Biochem. Sci., 18, 181-186.
56. Patil,A. and Nakamura,H. (2006) Disordered domains and high surface charge confer hubs with the ability to interact with multiple proteins in interaction networks. FEBS Lett., 580, 2041-2045.
57. Haynes,C., Oldfield,C.J., Ji,F., Klitgord,N., Cusick,M.E., Radivojac,P., Uversky,V.N., Vidal,M. and Iakoucheva,L.M. (2006) Intrinsic disorder is a common feature of hub proteins from four eukaryotic interactomes. PLoS Comput. Biol., 2, e100.
58. Dunker,A.K., Cortese,M.S., Romero,P., Iakoucheva,L.M. and Uversky,V.N. (2005) Flexible nets. the roles of intrinsic disorder in protein interaction networks. FEBS J., 272, 5129-5148.
59. Millard,C.J., Watson,P.J., Celardo,I., Gordiyenko,Y., Cowley,S.M., Robinson,C.V., Fairall,L. and Schwabe,J.W. (2013) Class I HDACs share a common mechanism of regulation by inositol phosphates. Mol. Cell, 51, 57-67.
60. Alqarni,S.S., Murthy,A., Zhang,W., Przewloka,M.R., Silva,A.P., Watson,A.A., Lejon,S., Pei,X.Y., Smits,A.H., Kloet,S.L. et al. (2014) Insight into the architecture of the NuRD complex: structure of the RbAp48-MTA1 subcomplex. J. Biol. Chem., 289, 21844-21855.
61. Lu,Y., Loh,Y.H., Li,H., Cesana,M., Ficarro,S.B., Parikh,J.R., Salomonis,N., Toh,C.X., Andreadis,S.T., Luckey,C.J. et al. (2014) Alternative splicing of MBD2 supports self-renewal in human pluripotent stem cells. Cell. Stem Cell., 15, 92-101.
62. Chen,L.M. and Chai,K.X. (2002) Prostasin serine protease inhibits breast cancer invasiveness and is transcriptionally regulated by promoter DNA methylation. Int. J. Cancer, 97, 323-329.
63. Chen,L.M., Hodge,G.B., Guarda,L.A., Welch,J.L., Greenberg,N.M. and Chai,K.X. (2001) Down-regulation of prostasin serine protease: a potential invasion suppressor in prostate cancer. Prostate, 48, 93-103.
64. Dawson,R., Muller,L., Dehner,A., Klein,C., Kessler,H. and Buchner,J. (2003) The N-terminal domain of p53 is natively unfolded. J. Mol. Biol., 332, 1131-1141.
65. Wells,M., Tidow,H., Rutherford,T.J., Markwick,P., Jensen,M.R., Mylonas,E., Svergun,D.I., Blackledge,M. and Fersht,A.R. (2008) Structure of tumor suppressor p53 and its intrinsically disordered N-terminal transactivation domain. Proc. Natl. Acad. Sci. U.S.A., 105, 5762-5767.
66. Krishnan,N., Koveal,D., Miller,D.H., Xue,B., Akshinthala,S.D., Kragelj,J., Jensen,M.R., Gauss,C.M., Page,R., Blackledge,M. et al. (2014) Targeting the disordered C terminus of PTP1B with an allosteric inhibitor. Nat. Chem. Biol., 10, 558-566.
67. Myung,J.K., Banuelos,C.A., Fernandez,J.G., Mawji,N.R., Wang,J., Tien,A.H., Yang,Y.C., Tavakoli,I., Haile,S., Watt,K. et al. (2013) An androgen receptor N-terminal domain antagonist for treating prostate cancer. J. Clin. Invest., 123, 2948-2960.
68. Uversky,V.N., Li,J. and Fink,A.L. (2001) Evidence for a partially folded intermediate in alpha-synuclein fibril formation. J. Biol. Chem., 276, 10737-10744.
69. Toth,G., Gardai,S.J., Zago,W., Bertoncini,C.W., Cremades,N., Roy,S.L., Tambe,M.A., Rochet,J.C., Galvagnion,C., Skibinski,G. et al. (2014) Targeting the intrinsically disordered structural ensemble of alpha-synuclein by small molecules as a potential therapeutic strategy for parkinson's disease. PLoS One, 9, e87133.
70. Berg,T., Cohen,S.B., Desharnais,J., Sonderegger,C., Maslyar,D.J., Goldberg,J., Boger,D.L. and Vogt,P.K. (2002) Small-molecule antagonists of Myc/Max dimerization inhibit myc-induced transformation of chicken embryo fibroblasts. Proc. Natl. Acad. Sci. U.S.A., 99, 3830-3835.
71. Hammoudeh,D.I., Follis,A.V., Prochownik,E.V. and Metallo,S.J. (2009) Multiple independent binding sites for small-molecule inhibitors on the oncoprotein c-myc. J. Am. Chem. Soc., 131, 7390-7401.